ADAP
Adaptimmune Therapeutics
ADAP
ADAP
76 hedge funds and large institutions have $150M invested in Adaptimmune Therapeutics in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 11 closing their positions.
Holders
76
Holders Change
-4
Holders Change %
-5%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
7
Increased
17
Reduced
21
Closed
11
Calls
$132K
Puts
$35K
Net Calls
+$97K
Net Calls Change
-$158K